Treating substance abuse among patients with schizophrenia

Psychiatric Services

Volumn 50, Issue 1, 1999, Pages 75-80

  Bellack, Alan S ^a   DiClemente, Carlo C ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DRUG DEPENDENCE TREATMENT; HUMAN; SCHIZOPHRENIA; SOCIOTHERAPY; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032957710     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.50.1.75     Document Type: Article

References (57)

1. Mueser KT, Bennett M, Kushner MG: Epidemiology of substance use disorders among persons with chronic mental illnesses. in Double Jeopardy: Chronic Mental Illness and Substance Use Disorders. Edited by Lehman AF, Dixon LB. Newark, NJ, Harwood Academic, 1995
2. Regier DA, Farmer MK, Rae DS, et al: Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264:2511-2518, 1990
3. Drake RE, Osher FC, Wallach MA: Alcohol use and abuse in schizophrenia: a prospective community study. Journal of Nervous and Mental Disease 177:408-414, 1989
4. Mueser KT, Yarnold PR. Bellack AS: Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatrica Scandinavica 85:48-55, 1992
5. Koob GF: Drugs of abuse: anatomy. pharmacology. and function of rewards pathways. TiPS 13:177-184, 1992
6. Hooley J: Expressed emotion: a review of the critical literature. Clinical Psychology Review 5:119-140, 1985
7. Cournos F. McKinnon K: HIV seroprevalence among people with severe mental illness in the US: a critical review. Clinical Psychology Review 17:259-269, 1997
8. Carey MP, Carey KB. Kalichman SC: Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clinical Psychology Review 17: 271-291, 1997
9. Goodman LA, Rosenberg SD, Mueser KT, et al: Physical and sexual assault history in women with serious mental illness: prevalence, impact, treatment, and future research directions. Schizophrenia Bulletin 23:685-696, 1997
10. Bellack AS: Cognitive rehabilitation for schizophrenia: is it possible? Is it necessary? Schizophrenia Bulletin 18:43-50, 1992
11. Dixon L, Haas G, Weiden PJ, et al: Drug abuse in schizophrenic patients: clinical correlates and reasons for use. American Journal of Psychiatry 148:224-230, 1991
12. Noordsy DS, Drake RE, Teague GB, et al: Subjective experiences related to alcohol use among schizophrenics. Journal of Nervous and Mental Disease 179:410-414, 1991
13. Mueser KT, Bellack AS, Douglas MS, et al: Prediction of social skill acquisition in schizophrenic and major affective disorder patients from memory and symptomatology. Psychiatry Research 32:281-296, 1991
14. Pope HG, Ioneseu-Pioggia M, Aizley HG. et al: Drug use and life style among college undergraduates in 1989: a comparison with 1969 and 1978. American Journal of Psychiatry 147:998-1001, 1990
15. Drake RE, McHugo GJ, Noordsy DL: Treatment of alcoholism among schizophrenic outpatients: 4-year outcomes. American Journal of Psychiatry 150:328-329, 1993
16. Lehman AF. Herron JD, Schwartz RP, et al: Rehabilitation for young adults with severe mental illness and substance use disorders. Journal of Nervous and Mental Disease 181:86-90, 1993
17. Blankertz LE, Cnaan RA: Assessing the impact of two residential programs for dually diagnosed homeless individuals. Social Service Review 68:536-560, 1994
18. Jerrell JM, Ridgely MS: Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease 183:566-576, 1995
19. Lehman AF. Dixon LB (eds): Double Jeopardy: Chronic Mental Illness and Substance Use Disorders. Newark. NJ, Harwood Academic, 1995
20. Carey KB: Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Mental Health Journal 32:291-306, 1996
21. Osher FC. Kofoed LL: Treatment of patients with psychiatric and psychoactive substance abuse disorder. Hospital and Community Psychiatry 40:1025-1030. 1989
22. McHugo GJ, Drake RE. Burton HL. et al: A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease 183:762-767. 1995
23. Prochaska JO. DiClemente CC, Norcross JC: In search of how people change: applications to addictive behaviors. American Psychologist 47:1102-1114. 1992
24. Prochaska JO, DiClemente CC: Stages of change in the modification of problem behaviors. in Progress in Behavior Modification, no 28. Edited by Hersen M. Eisler RM, Miller PM. New York. Academic. 1992
25. DiClemente CC: Changing addictive behaviors: a process perspective. Current Directions in Psychological Science 2:101-106, 1993
26. Prochaska JO, DiClemente CC: The Transtheoretical Approach: Crossing the Traditional Boundaries of Therapy. Malabar. Fla. Krieger, 1984
27. DiClemente CC: If behaviors change. can personality be far behind? in Can Personality Change? Edited by Heatherton T. Weinberger J. Washington, DC. American Psychological Association, 1994
28. DiClemente CC: Motivational interviewing and the stages of change, in Motivational Interviewing: Preparing People to Change Addictive Behavior. Edited by Miller WR. Rollnick S. New York. Guilford, 1991
29. Velicer WF, DiClemente CC, Prochaska JO, et al: Decisional balance measure for assessing and predicting smoking status. Journal of Personality and Social Psychology 48:1279-1289, 1985
30. DiClemente CC, Fairhurst SK, Piotrowski NA: The role of self-efficacy in the addictive behaviors, in Self-Efficacy. Adaptation, and Adjustment: Theory, Research, and Application. Edited by James Madduz. New York, Plenum, 1995
31. Rothfleisch J: Comparison of Two Measures of Stages of Change Among Drug Abusers. Unpublished doctoral dissertation, University of Houston, Department of Psychology. May 1997
32. Velaquez M: Psychiatric Severity and Behavior Change in Alcoholism: The Relation of the Transtheoretical Model Variables to Psychiatric Distress in Dually Diagnosed Patients. Unpublished doctoral dissertation, University of Texas School of Public Health, May 1997
33. Hall SM, Wasserman DA, Havassy BE: Relapse prevention, in Improving Drug Abuse Treatment. NIDA Research Monograph 106. Edited by Pickens RW. Leukefeld CG. Schuster CR. Rockville. Md. National Institute on Drug Abuse, 1991
34. Miller WR: Increasing motivation to change. in Handbook of Alcoholism Treatment Approaches. Edited by Hester RK. Miller WR. New York, Pergamon, 1989
35. Rounsaville BJ. Carroll KM: Individual psychotherapy for drug abusers, in Substance Abuse: A Comprehensive Textbook, 2nd ed. Edited by Lowinson JH, Ruiz P, Millman RB. et al. Baltimore, Williams & Wilkins, 1992
36. Sandberg GG, Marlatt GA: Relapse prevention, in Clinical Manual of Chemical Dependence. Edited by Ciraulo DA, Shader RI. Washington, DC, American Psychiatric Press, 1991
37. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44:660-669, 1987
38. Andreasen NC, Flaum M, Swayze VW, et al: Positive and negative symptoms in schizophrenia: a critical reappraisal. Archives of General Psychiatry 47:615-621. 1990
39. Carpenter WTJ, Heinrichs DW, Alphs LD: Treatment of negative symptoms. Schizophrenia Bulletin 11:440-452, 1985
40. Blanchard JJ, Mueser KT. Bellack AS: Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophrenia Bulletin 24:413-424, 1998
41. Bellack AS, Mueser KT: Psychosocial treatment for schizophrenia. Schizophrenia Bulletin 19:317-336, 1993
42. Paul GL. Lentz RJ: Psychosocial Treatment of Chronic Mental Patients: Milieu Versus Social-Learning Programs. Cambridge, Mass, Harvard University Press, 1977
43. Gray JA, Feldon J. Rawlins JNP. et al: The neuropsychology of schizophrenia. Behavioral and Brain Sciences 14:1-84, 1991
44. Goldberg TE. Gold JM: Neurocognitive deficits in schizophrenia. in Schizophrenia. Edited by Hirsch SR, Weinberger DR, Cambridge, England, Blackwell Science, 1995
45. Bellack AS, Morrison RL, Mueser KT: Social problem solving in schizophrenia. Schizophrenia Bulletin 15:101-116, 1989
46. Saykin AJ, Shtasel DL. Gur RE. et al: Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry 51: 124-131, 1994
47. Spolin HE, Strauss ME: Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology 4:367-380, 1989
48. Green MF, Marshall BD, Wirshing WC. et al: Does risperidone improve verbal working memory in treatment-resistant schizophrenia. American Journal of Psychiatry 154:799-804, 1997
49. Hemsley DR: Schizophrenia: a cognitive model and its implications for psychological intervention. Behavior Modification 20: 139-169, 1995
50. Morrison RL. Bellack AS: The social functioning of schizophrenic patients: clinical and research issues. Schizophrenia Bulletin 13:715-726, 1987
51. Lewine RJ, Watt NF, Prentky RA, et al: Childhood social competence in functionally disordered psychiatric patients and in normals. Journal of Abnormal Psychology 89:132-138, 1980
52. Cornblatt BA. Lenzenweger MF. Dworkin RH. et al: Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. British Journal of Psychiatry 161(suppl 18):59-64, 1992
53. Miller WR, Rollnick S (eds): Motivational Interviewing: Preparing People to Change Addictive Behavior. New York. Guilford. 1991
54. Test MA, Wallisch LS, Allness DJ, et al: Substance use in young adults with schizophrenic disorders. Schizophrenia Bulletin 15:465-476, 1989
55. Annis HM, Davis CS: Relapse prevention, in Handbook of Alcoholism Treatment Approaches. Edited by Hester RK, Miller WR. New York. Pergamon, 1989
56. Hester RK. Miller WR: Self-control training, ibid
57. Marlatt GA. Gordon JR: Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York, Guilford. 1985